TickerFacts.

Nature's Sunshine Products Inc (NATR): Share Repurchases

Annual figures by period end, from SEC filings.

$16.31M
Year ended 2025-12-31
$6.52M
Trailing 12 months to 2026-06-30
+6.3%
3-year compound annual growth
+9.4%
10-year compound annual growth
2013-12-31: $2.55M2014-12-31: $7.46M2015-12-31: $6.64M2016-12-31: $02017-12-31: $02020-12-31: $02021-12-31: $7.42M2022-12-31: $13.57M2023-12-31: $6.40M2024-12-31: $8.86M2025-12-31: $16.31M$16.31M
2013-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$16.31M+84.1%2026-03-10, From 2025-01-01
2024-12-31$8.86M+38.5%2026-03-10, From 2024-01-01
2023-12-31$6.40M-52.9%2025-03-11, From 2023-01-01
2022-12-31$13.57M+82.8%2024-03-12, From 2022-01-01
2021-12-31$7.42Mn/a2023-03-16, From 2021-01-01
2020-12-31$0n/a2022-03-08, From 2020-01-01
No annual figure between 2017-12-31 and 2020-12-31.
2017-12-31$0n/a2018-03-16, From 2017-01-01
2016-12-31$0-100.0%2018-03-16, From 2016-01-01
2015-12-31$6.64M-10.9%2018-03-16, From 2015-01-01
2014-12-31$7.46M+192.8%2017-03-14, From 2014-01-01
2013-12-31$2.55Mn/a2016-03-14, From 2013-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Nature's Sunshine Products Inc (NATR)2025-12-31$16.31M+84.1%
BridgeBio Pharma, Inc. (BBIO)2025-12-31$48.28Mn/a
HUTCHMED (China) Ltd (HCM)2024-12-31$36.06M+297.6%
Innoviva, Inc. (INVA)2025-12-31$4.53M-69.3%
Organogenesis Holdings Inc. (ORGO)2024-12-31$25.48Mn/a
Opko Health, Inc. (OPK)2025-12-31$47.04M-47.9%
Amphastar Pharmaceuticals, Inc. (AMPH)2025-12-31$75.59M-11.6%
Pacira BioSciences, Inc. (PCRX)2025-12-31$148.33M+493.3%
Emergent BioSolutions Inc. (EBS)2025-12-31$24.90Mn/a

Compare NATR, BBIO, HCM, INVA side by side · Screen every company in Pharmaceutical Preparations ↗